Healthcare provider profile · identity verified

Benjamin Joseph Linden, M.D.

Family Practice · HIGHLAND VILLAGE, TX · NPI 1083971980

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	537	161
Atorvastatin Calcium	Atorvastatin Calcium	308	93
Levothyroxine Sodium	Levothyroxine Sodium	303	82
Losartan Potassium	Losartan Potassium	194	61
Amlodipine Besylate	Amlodipine Besylate	187	66
Olmesartan Medoxomil	Olmesartan Medoxomil	180	61
Pantoprazole Sodium	Pantoprazole Sodium	169	53
Gabapentin	Gabapentin	135	42
Omeprazole	Omeprazole	129	38
Tamsulosin Hcl	Tamsulosin Hcl	128	44
Mounjaro	Tirzepatide	126	24
Trazodone Hcl	Trazodone Hcl	126	35
Lisinopril	Lisinopril	125	39
Ozempic	Semaglutide	122	27
Ezetimibe	Ezetimibe	112	37
Sertraline Hcl	Sertraline Hcl	109	33
Metformin Hcl	Metformin Hcl	108	34
Metformin Hcl Er	Metformin Hcl	106	30
Carvedilol	Carvedilol	105	33
Metoprolol Succinate	Metoprolol Succinate	93	32
Simvastatin	Simvastatin	81	24
Synthroid	Levothyroxine Sodium	75	16
Pravastatin Sodium	Pravastatin Sodium	73	23
Alprazolam	Alprazolam	72	20
Methylprednisolone	Methylprednisolone	68	60
Potassium Chloride	Potassium Chloride	65	26
Albuterol Sulfate Hfa	Albuterol Sulfate	60	43
Eliquis	Apixaban	60	18
Furosemide	Furosemide	59	23
Alendronate Sodium	Alendronate Sodium	57	21
Jardiance	Empagliflozin	53	16
Duloxetine Hcl	Duloxetine Hcl	51	16
Ropinirole Hcl	Ropinirole Hcl	50	16
Fluticasone Propionate	Fluticasone Propionate	48	20
Hydrochlorothiazide	Hydrochlorothiazide	48	19
Eszopiclone	Eszopiclone	47	suppressed
Meloxicam	Meloxicam	47	17
Pregabalin	Pregabalin	47	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	46	16
Spironolactone	Spironolactone	46	17
Escitalopram Oxalate	Escitalopram Oxalate	44	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Estradiol	Estradiol	42	14
Metoprolol Tartrate	Metoprolol Tartrate	42	15
Pioglitazone Hcl	Pioglitazone Hcl	42	15
Montelukast Sodium	Montelukast Sodium	41	13
Allopurinol	Allopurinol	40	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	34
Celecoxib	Celecoxib	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	22
Azelastine Hcl	Azelastine Hcl	37	17
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Valsartan	Valsartan	34	suppressed
Azithromycin	Azithromycin	32	31
Bupropion Xl	Bupropion Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	25
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	26
Ondansetron Odt	Ondansetron	28	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	11
Progesterone	Progesterone, Micronized	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Farxiga	Dapagliflozin Propanediol	26	suppressed
Xarelto	Rivaroxaban	25	suppressed
Lovastatin	Lovastatin	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	18
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	20	20
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Famotidine	Famotidine	20	suppressed
Finasteride	Finasteride	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Atenolol	Atenolol	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Prednisone	Prednisone	17	11
Ciclopirox	Ciclopirox	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	12
Levofloxacin	Levofloxacin	15	13
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Propranolol Hcl	Propranolol Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ramipril	Ramipril	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Diazepam	Diazepam	14	suppressed
Fluconazole	Fluconazole	14	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Indapamide	Indapamide	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Temazepam	Temazepam	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error